BofA lowered the firm’s price target on Westlake (WLK) to $83 from $84 and keeps a Buy rating on the shares after the company announced a plan to shut down several production facilities in North America as part of a broader restructuring initiative. Despite adding $100M to the firm’s 2026 EBITDA bridge from the actions, the firm is lowering its 2026 EBITDA estimate to $1.48B from $1.552B, given lower assumed product pricing and higher feedstock costs.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WLK:
- Westlake Corporation’s Strategic Restructuring and Cost-Saving Measures Justify Buy Rating Amid Short-Term Challenges
- Westlake price target lowered to $80 from $90 at Morgan Stanley
- Westlake Corporation Announces Major Facility Closures
- Westlake to cut 295 employees, cease certain NA chlorovinyl production plants
- Westlake price target lowered to $75 from $88 at Citi